Загрузка...
Prothrombotic changes in patients with COVID‐19 are associated with disease severity and mortality
BACKGROUND AND AIMS: Patients with severe coronavirus disease 2019 (COVID‐19) are at significant risk of thrombotic complications. However, their prothrombotic state is incompletely understood. Therefore, we measured in vivo activation markers of hemostasis, plasma levels of hemostatic proteins, and...
Сохранить в:
| Опубликовано в: : | Res Pract Thromb Haemost |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7845083/ https://ncbi.nlm.nih.gov/pubmed/33537537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12462 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|